Asahi Kasei Finishes Second Plant for Ceolus Microcrystalline Cellulose

The plant is intended to raise supply capacity and enhance the supply stability through production at multiple sites.

Asahi Kasei has completed the construction of its second plant for Ceolus microcrystalline cellulose (MCC), a tablet binder for pharmaceuticals. The new facility in Okayama, Japan, underscores the company’s commitment to meet the substantially growing demand for its MCC product. According to the company, demand for Ceolus is growing, most notably for the proprietary high-performance grades Ceolus. “The increased capacity at this new plant will enable us to provide a more stable supply o...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters